Adjuvant Imiquimod Therapy to Reduce Recurrence Rate in Patients After Surgical Therapy of Anal HPV-lesions

Trial Profile

Adjuvant Imiquimod Therapy to Reduce Recurrence Rate in Patients After Surgical Therapy of Anal HPV-lesions

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 20 Oct 2017

At a glance

  • Drugs Imiquimod (Primary)
  • Indications Condylomata acuminata; Human papillomavirus infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Oct 2017 Last checked against ClinicalTrials.gov record
    • 12 Oct 2017 Planned initiation date changed from 1 Oct 2017 to 1 Dec 2017.
    • 22 Sep 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top